Company Summary:

Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.

Position Summary:

This is a six-month contract position. The Data Entry Associate will be performing date entry into our LIMS in support of High Throughput production for DNA plasmid production. This individual will work closely with the Lab Manager and Manufacturing Team to enter production data into our Lab Management System (LMS). Data entry will include dates process steps are complete along with supporting notes such that senior leadership has a real time snapshot of projects progressing through the manufacturing process.

Key Responsibilities:

The successful candidate will work both independently and as part of a collaborative team to…

• Enter data in a timely and accurate manner into Tessera's Benchling LMS
• Update existing data
• Meet daily with the Lab Manager to pass along project updates
• Work with the Manufacturing Team to obtain status changes
• Maintain and adhere to safe work habits and all applicable safety procedures and guidelines
• Inspire and constantly strive to make Tessera a great place to work and respected for the quality of its people, products, and clients

Basic Qualifications:

• High School Diploma or an Associate's Degree with 1-2 years of experience is required
• Excellent typing skills
• Working understanding of databases
• Attention to detail

More About Flagship Pioneering

Flagship Pioneering has conceived of and created companies such as Moderna Therapeutics (NASDAQ: MRNA), Editas Medicine (NASDAQ: EDIT), Omega Therapeutics (NASDAQ: OMGA), Seres Therapeutics (NASDAQ: MCRB), and Indigo Agriculture. Since its launch in 2000, Flagship has applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures. In 2021, Flagship Pioneering was ranked 12th globally on Fortune's "Change the World" list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, "FSP") do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering's internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.